In a small randomized control study, researchers in China found that HIV drug Kaletra and influenza drug Arbidol have no effect on patients with mild to moderately severe COVID-19 infections.
privacy policy | terms of use | contact us | advertise | pharma jobs | pharma blogs | facebook | twitter
Copyright © 2025,